George Yancopoulos - Net Worth and Insider Trading

George Yancopoulos Net Worth

The estimated net worth of George Yancopoulos is at least $943 Million dollars as of 2024-11-13. George Yancopoulos is the Bd. Co-Chair, President & CSO of Regeneron Pharmaceuticals Inc and owns about 1,148,844 shares of Regeneron Pharmaceuticals Inc (REGN) stock worth over $943 Million. Details can be seen in George Yancopoulos's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that George Yancopoulos has not made any transactions after 2024-05-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of George Yancopoulos

To

George Yancopoulos Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, George Yancopoulos owns 1 companies in total, including Regeneron Pharmaceuticals Inc (REGN) .

Click here to see the complete history of George Yancopoulos’s form 4 insider trades.

Insider Ownership Summary of George Yancopoulos

Ticker Comapny Transaction Date Type of Owner
REGN Regeneron Pharmaceuticals Inc 2024-05-16 director & President and CSO

George Yancopoulos Latest Holdings Summary

George Yancopoulos currently owns a total of 1 stock. George Yancopoulos owns 1,148,844 shares of Regeneron Pharmaceuticals Inc (REGN) as of May 16, 2024, with a value of $943 Million.

Latest Holdings of George Yancopoulos

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
REGN Regeneron Pharmaceuticals Inc 2024-05-16 1,148,844 821.00 943,200,924

Holding Weightings of George Yancopoulos


George Yancopoulos Form 4 Trading Tracker

According to the SEC Form 4 filings, George Yancopoulos has made a total of 10 transactions in Regeneron Pharmaceuticals Inc (REGN) over the past 5 years, including 0 buys and 10 sells. The most-recent trade in Regeneron Pharmaceuticals Inc is the sale of 50,000 shares on May 16, 2024, which brought George Yancopoulos around $49 Million.

Insider Trading History of George Yancopoulos

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

George Yancopoulos Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

George Yancopoulos Ownership Network

Ownership Network List of George Yancopoulos

No Data

Ownership Network Relation of George Yancopoulos

Insider Network Chart

George Yancopoulos Owned Company Details

What does Regeneron Pharmaceuticals Inc do?

Who are the key executives at Regeneron Pharmaceuticals Inc?

George Yancopoulos is the director & President and CSO of Regeneron Pharmaceuticals Inc. Other key executives at Regeneron Pharmaceuticals Inc include SVP Commercial Marion Mccourt , VP & Controller Christopher R. Fenimore , and EVP Research Andrew J Murphy .

Regeneron Pharmaceuticals Inc (REGN) Insider Trades Summary

Over the past 18 months, George Yancopoulos made 3 insider transaction in Regeneron Pharmaceuticals Inc (REGN) with a net sale of 83,696. Other recent insider transactions involving Regeneron Pharmaceuticals Inc (REGN) include a net sale of 10,814 shares made by Marion Mccourt , a net sale of 1,400 shares made by Arthur F Ryan , and a net sale of 7,918 shares made by Bonnie L Bassler .

In summary, during the past 3 months, insiders sold 26,837 shares of Regeneron Pharmaceuticals Inc (REGN) in total and bought 0 shares, with a net sale of 26,837 shares. During the past 18 months, 315,919 shares of Regeneron Pharmaceuticals Inc (REGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 315,919 shares.

Regeneron Pharmaceuticals Inc (REGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Regeneron Pharmaceuticals Inc Insider Transactions

No Available Data

George Yancopoulos Mailing Address

Above is the net worth, insider trading, and ownership report for George Yancopoulos. You might contact George Yancopoulos via mailing address: 777 Old Saw Mill River Road, Tarrytown Ny 10591.